Projects

Alessandro VATRELLA Projects

4 Funded projects
Filter
"Health4.0 Platf O2rm - Piattaforma 4.0 per l'assistenza domiciliare integrata ai malati affetti da Insufficienza Respiratoria in OLT" Prog n. F/350225/05/X60 COR: 22510394
DepartmentDipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED
Principal InvestigatorVATRELLA Alessandro (Project Coordinator)
FundingFinanziamenti da bandi nazionali Ministeriali ed altri EEPP
FundersMinistero delle imprese e del made in Italy
Cost871.062,50 euro
Project duration6 November 2023 - 5 November 2026
Detail
Study aim is understanding RBPs role in (1) EGFR-TKI-induced modification of immune-related proteins levels, such as CD47 and PD-L1, with consequent impact on evasion of NK cell-mediated cytotoxicity; (2) EGFR-TKI-promoted cytokine secretion and impact on EGFR-TKI-resistance acquisition, tumor cell migration and invasion. We will use sensitive/resistant NSCLC cell lines with physiological and exog
DepartmentDipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED
Principal InvestigatorDAL COL JESSICA (Project Coordinator)
FundingUniversity funds
FundersUniversità  degli Studi di SALERNO
Cost20.037,30 euro
Project duration31 July 2023 - 31 July 2026
Detail
The mechanisms accounting for sustained airway inflammation in asthma, a chronic respiratory disease affecting 6-9% of the EU population, have yet to be fully elucidated. More research is needed to define practical, yet reliable biomarkers in the clinical characterization and management of this condition. Inflammation in asthma is driven by a type 2-biased, dysregulated adaptive response to enviro
DepartmentDipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED
Principal InvestigatorCASOLARO Vincenzo (Project Coordinator)
FundingUniversity funds
FundersUniversità  degli Studi di SALERNO
Cost18.313,12 euro
Project duration25 July 2022 - 25 July 2025
Detail
Abbiamo dimostrato che concentrazioni terapeutiche di aspirina inibiscono l¿attivazione di geni NFAT-dipendenti, come la IL-4 e il CD154, nelle cellule T CD4+ attivate. Tuttavia, alle stesse concentrazioni l¿aspirina potenzia in queste cellule l¿attività del fattore NFATc2, verosimilmente attraverso il coinvolgimento di meccanismi alternativi. Desideriamo estendere queste osservazioni ai granuloci
DepartmentDipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED
Principal InvestigatorCASOLARO Vincenzo (Project Coordinator)
FundingUniversity funds
FundersUniversità  degli Studi di SALERNO
Cost14.223,99 euro
Project duration22 November 2021 - 22 November 2024
Detail

  Data source U-GOV dal 1 Gennaio 2013